New Zealand researchers have been given the green light to trial new treatments on multiple sclerosis patients using anti-psychotic drugs.
The researchers from Victoria University believe they may be able to reduce the symptoms of this debilitating disease using commonly prescribed drugs.
They say a lower dosage of Clozapine and Risperidone, which treat depression and schizophrenia, can be used to treat MS.
Victoria University researcher Dr Laura Green says the study shows that using the drugs are reducing inflammation and even stopping inflammation in its tracks.
Dr Anne La Flamme says while there are drugs for people who suffer relapses, there has been nothing for those whose condition is progressive.
"It's a different pathway, different way that they are treating MS as to how they would be treating schizophrenia," she says.
"To be able to do something that may benefit them directly is invaluable."
Multiple-sclerosis (MS) is a disease that inflames the nerve cells in the brain and spinal cord and affects 3,000 New Zealanders. Some of the symptoms of MS are blurred vision and chronic pain.